Pheochromocytoma and paraganglioma
HPH Neumann, WF Young Jr… - New England journal of …, 2019 - Mass Medical Soc
Pheochromocytoma and Paraganglioma Pheochromocytoma and paraganglioma are
related tumors that differ mainly in location; pheochromocytomas are adrenal, and …
related tumors that differ mainly in location; pheochromocytomas are adrenal, and …
Medullary thyroid cancer: management guidelines of the American Thyroid Association
Background: Inherited and sporadic medullary thyroid cancer (MTC) is an uncommon and
challenging malignancy. The American Thyroid association (ATA) chose to create specific …
challenging malignancy. The American Thyroid association (ATA) chose to create specific …
RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma
GW Krampitz, JA Norton - Cancer, 2014 - Wiley Online Library
The rapid technical advances in molecular biology and accelerating improvements in
genomic and proteomic diagnostics have led to increasingly personalized strategies for …
genomic and proteomic diagnostics have led to increasingly personalized strategies for …
Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients
Z Erlic, L Rybicki, M Peczkowska, H Golcher… - Clinical Cancer …, 2009 - AACR
Purpose: Six pheochromocytoma susceptibility genes causing distinct syndromes have
been identified; approximately one of three of all pheochromocytoma patients carry a …
been identified; approximately one of three of all pheochromocytoma patients carry a …
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10
K Frank‐Raue, LA Rybicki, Z Erlic… - Human …, 2011 - Wiley Online Library
Multiple endocrine neoplasia type 2 is characterized by germline mutations in RET. For exon
10, comprehensive molecular and corresponding phenotypic data are scarce. The …
10, comprehensive molecular and corresponding phenotypic data are scarce. The …
Pheochromocytomas and paragangliomas
SG Tevosian, HK Ghayee - Endocrinology and Metabolism …, 2019 - endo.theclinics.com
Pheochromocytomas (PCCs) are rare neuroendocrine tumors. About 80% to 85% of these
cancers arise from chromaffin cells residing in the adrenal medulla. The remaining 15% to …
cancers arise from chromaffin cells residing in the adrenal medulla. The remaining 15% to …
A decade (2001–2010) of genetic testing for pheochromocytoma and paraganglioma
A Buffet, A Venisse, V Nau, I Roncellin… - Hormone and …, 2012 - thieme-connect.com
The identification of 9 susceptibility genes for paraganglioma/pheochromocytoma between
2001and 2010 has led to the development of routine genetic tests. To study the evolution in …
2001and 2010 has led to the development of routine genetic tests. To study the evolution in …
GENETICS IN ENDOCRINOLOGY: The genetics of phaeochromocytoma: using clinical features to guide genetic testing
Phaeochromocytoma is a rare, usually benign, tumour predominantly managed by
endocrinologists. Over the last decade, major advances have been made in understanding …
endocrinologists. Over the last decade, major advances have been made in understanding …
Genetic and clinical features of multiple endocrine neoplasia types 1 and 2
C Romei, E Pardi, F Cetani, R Elisei - Journal of oncology, 2012 - Wiley Online Library
Multiple endocrine neoplasia (MEN) are clinical inherited syndromes affecting different
endocrine glands. Three different patterns of MEN syndromes can occur (MEN 1, MEN 2A …
endocrine glands. Three different patterns of MEN syndromes can occur (MEN 1, MEN 2A …
Endocrine hypertension
W Young - Endocrine Abstracts, 2011 - endocrine-abstracts.org
Objective: To review the first reported cases of successfully treated pheochromocytoma and
primary aldosteronism and document the diagnostic and therapeutic advances that have …
primary aldosteronism and document the diagnostic and therapeutic advances that have …